All In Biotech

Drug Trial Radar · NCT03012945

Epidural Anesthesia-analgesia and Long-term Outcome

Impact of Epidural Anesthesia-analgesia on Long-term Outcome in Elderly Patients After Surgery: 5-year Follow-up of a Multicenter Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Jul 8, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,802 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,802

Actual

Start

Nov 1, 2014

Primary completion

Sep 30, 2019

Study completion Sep 30, 2019

Sponsor

Lead sponsor
Peking University First HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Peking University People's Hospital; Peking University Third Hospital; Beijing Hospital; Beijing Shijitan Hospital, Capital Medical University; Peking University
First posted
Jan 6, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 60 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Surgical resection is one of the most important treatments for resectable cancer; on the other hand, cancer recurrence and/or metastasis are the major reasons of treatment failure. The development of recurrence/metastasis after cancer surgery mostly depends on the balance between the immunity of human body and the capability of implantation, proliferation and neovascularization of the residual cancer. Preclinical and retrospective clinical studies suggest that anaesthetic management may affect the long-term outcomes after cancer surgery. The investigators hypothesize that use of epidural anesthesia-analgesia may improve long-term survival in elderly patients after major surgery for cancer.

Conditions

  • Elderly
  • Malignant Tumor
  • Surgical Resection
  • Epidural Anesthesia
  • Long-term Outcome

Interventions

  • Combined epidural-general anesthesiaDrug

    Combined epidural-general anesthesia and postoperative epidural analgesia. General anesthesia is performed as that in the general anesthesia group. Epidural anesthesia is performed with ropivacaine. Epidural analgesia is performed with a mixture of ropivacaine and sufentanil.

  • General anesthesiaDrug

    General anesthesia and postoperative intravenous analgesia. General anesthesia is performed with propofol induction and propofol and/or sevoflurane maintenance. Intravenous analgesia is performed with morphine.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall survival after surgery.Time frame: Up to median 5 years after surgery.

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Shijitan Hospital

    Beijing, China

  • Peking University People's Hospital

    Beijing, China

  • Peking University Third Hospital

    Beijing, China

  • Beijing Hospital

    Beijing, China

  • Peking University First Hospital

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.